3 November 2015 - Anika Therapeutics, Inc., a orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced Health Canada approval of Cingal as a medical device to treat pain associated with osteoarthritis of the knee.

For more details, go to: http://ir.anikatherapeutics.com/releasedetail.cfm?ReleaseID=940094